Ablynx | Evaluate

September 19, 2018

Novo casts its net wider but shrinks in the process

The company’s plan to cut jobs and look at external deals could be a sign that it is becoming more like other big pharmas.

August 14, 2018

Most valuable unpartnered assets reveal a changing of the guard

Annual analysis shows a new crop of biotech assets with ballooning valuations and no major partners.

April 03, 2018

First-quarter acquisition activity lifts hopes for a big year

After a slow 2017, first-quarter biopharma acquisition activity could signal a turnaround.

April 03, 2018

Rigel gets bad news ahead of its biggest date yet

March 29, 2018

Snippet roundup: Edge blunted by trial's end, but Esperion soars on bempedoic acid hopes

February 13, 2018

Roche eyes diabetes success where Regeneron failed

February 01, 2018

Not dry January, but no M&A cash flood either

January 29, 2018

Sanofi's Ablynx buy leaves no doubt about its pipeline troubles

January 22, 2018

Sanofi bets against haemophilia gene therapy

January 10, 2018

M&A: 2017 proves snooze-worthy on the acquisition front

Pharma and biotech takeover activity slumps to a five-year low in 2017.

January 09, 2018

JP Morgan day one roundup – disappointments set the tone

Load More